Pathogenetic substantiation of application of PROBITOX PET for dyspepsy in dogs and cats

Abstract

The purpose of the study is to study the effect of the drug Probitox Pet clinical indicators in dogs and cats with dyspeptic disorders. For the study, groups of 5 dogs and 5 cats kept at home in the city of St. Petersburg over 1.5 years old were formed. All animals showed signs of dyspepsia for 3 days or more. The diagnosis was confirmed by laboratory methods. For the treatment of dyspepsia, the drug Probitox Pet was prescribed for 7 days at a dosage of 1 tablet for every 5 kg of animal weight 2 times a day. Already 2 -4 days after the start of taking the drug in animals, normal appetite was noted, a decrease in the number of bowel movements, the termination of vomiting, flatulence and diarrhea, feces acquired a normal shape and consistency. On the 8th day after the start of the drug, clinical tests of blood and feces were repeated, which confirmed the positive dynamics. Our studies confirm the effectiveness of the drug Probitox Pet, which can be recommended for the relief of symptoms and treatment of dyspepsia in cats and dogs.